Clinical trial
Photodynamic Therapy (PDT) With Metvix Cream 160 mg/g Versus PDT With Placebo…
NCT00472108 · Galderma R&D, Industry · Completed
Key facts
| NCT number | NCT00472108 |
|---|---|
| Title | Photodynamic Therapy (PDT) With Metvix Cream 160 mg/g Versus PDT With Placebo Cream in Participants With Primary Nodular Basal Cell Carcinoma |
| Official title | A Multicenter, Phase III, Double Blind Study of Photodynamic Therapy (PDT) With Metvix 160 mg/g Cream in Comparison to PDT With Placebo Cream in Patients With Primary Nodular Basal Cell Carcinoma |
| Lead sponsor | Galderma R&D, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Basal Cell Carcinoma |
| Intervention type | Drug, Radiation |
| Interventions | Photodynamic Therapy (PDT), Metvix cream, Placebo Cream |
| Enrollment | 65 |
| Start date | Dec 1, 2000 |
| Primary completion | Apr 1, 2002 |
| Completion | Apr 1, 2002 |
| First posted | May 11, 2007 |
| Last update posted | Aug 5, 2024 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: